Medico-legal insurance implications of sickle cell anemia.
作者信息
Gullattee A C
出版信息
J Natl Med Assoc. 1973 Sep;65(5):415-9.
Abstract
摘要
相似文献
1
Medico-legal insurance implications of sickle cell anemia.
J Natl Med Assoc. 1973 Sep;65(5):415-9.
2
Sickle cell anemia: a legal conspectus.
J Natl Med Assoc. 1972 Nov;64(6):554-5.
3
Overview of humanistic progress in sickle cell anemia during the past 10 years.
Am J Pediatr Hematol Oncol. 1983 Winter;5(4):352-9. doi: 10.1097/00043426-198324000-00007.
4
Editorial: The sickle cell complexity.
JAMA. 1974 Apr 29;228(5):608-9.
5
Legal and ethical issues in newborn screening.
Pediatrics. 1989 May;83(5 part 2):894-6.
6
Sickle cell disease in a "postracial" America.
J Natl Med Assoc. 2009 Oct;101(10):1065-6. doi: 10.1016/s0027-9684(15)31075-0.
7
Some Lives Matter: The Dirty Little Secret of the U.S. Health Care System.
Hastings Cent Rep. 2020 Sep;50(5):3-4. doi: 10.1002/hast.1176.
8
Mandatory screening for sickle-cell anemia.
N Engl J Med. 1973 Oct 18;289(16):865-6.
9
Awareness of sickle cell anemia among negroes of Richmond, Va.
Public Health Rep (1896). 1969 Nov;84(11):949-53.
10
Some negative aspects of state health departments' policies related to screening for sickle cell anemia.
Am J Public Health. 1974 Mar;64(3):217-21. doi: 10.2105/ajph.64.3.217.
引用本文的文献
1
Sickle cell trait and multisystem trauma: an unaddressed urgent knowledge gap.
Trauma Surg Acute Care Open. 2022 Jun 5;7(1):e000955. doi: 10.1136/tsaco-2022-000955. eCollection 2022.
2
Sickle cell anaemia: epidemiology and cost of illness.
Pharmacoeconomics. 2002;20(6):357-66. doi: 10.2165/00019053-200220060-00001.
Zotero 插件